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The effect of endogenous glutamate on neurite outgrowth from cerebellar granule cells in culture was exam- 
ined. Neurite outgrowth was inhibited by enzymatic removal of endogenous glutamate from the culture me- 
dium. The broad-spectrum glutamate r ceptor antagonist kynurenate also inhibited neurite outgrowth from 
granule cells in serum-containing and serum-free cultures; the inhibition by kynurenate was reversed by exo- 
genous glutamate. Neurite outgrowth was inhibited to the same extent by the NMDA receptor antagonist 
APV. These results indicate that endogenous glutamate, possibly released by granule cells themselves, stimu- 
lated neurite outgrowth through activation of the NMDA class of glutamate receptors. Activation of 
NMDA receptors on developing neurons may be an important mechanism for the regulation of neuronal 
growth and differentiation. 
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1. INTRODUCTION 
A great deal of attention has been paid to the 
isolation of factors that regulate survival and dif- 
ferentiation of CNS neurons [1] in the way that 
NGF acts on peripheral sympathetic and sensory 
neurons [2]. So far, limited progress has been 
made in the precise identification of such mole- 
cules. One possibility is that conventional neuro- 
transmitters could regulate neuronal differentia- 
tion. Glutamate is a major excitatory neurotrans- 
mitter in the CNS which acts on three receptor 
types classified on the basis of their agonists as 
quisqualate, kainate or N-methyl-D-aspartate 
(NMDA) receptors [3,4]. Activation of NMDA but 
not the other two classes of glutamate receptors 
results in the opening of channels that allow Ca 2+ 
influx [5] and leads to a rise in cytosolic free Ca 2+ 
[6,7]. It has been suggested that the growth of 
neurites from isolated neurons is controlled by the 
level of cytosolic alcium in the growing tip of the 
neurite [8-10] and therefore activation of NMDA 
receptors is a potential mechanism for the control 
of neurite growth. 
Immature cerebellar granule cells in culture 
release glutamate in both a basal- and 
depolarisation-dependent fashion [11,12]. In addi- 
tion, these cells possess NMDA receptors [13] 
which are linked to channels with a conductance of
50 pS [14,15]. We have examined the possibility 
that endogenous glutamate acting through NMDA 
receptors stimulates neurite outgrowth from 
cerebellar granule cells in culture. 
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2. MATERIALS AND METHODS 
Cerebellar granule cells were dissociated from 
the cerebella of 4 or 5-day-old rats by trypsin treat- 
ment [16,17], resuspended in culture medium and 
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plated at a cell density of 1 × 103/mm 2onto poly- 
L-lysine-coated glass coverslips in the wells of a 
24-well tray. Culture medium was either serum + 
(Eagle's minimal essential medium containing 10070 
fetal calf serum, 2.5070 chick embryo extract, 
100/zg/ml gentamycin, 33 mM glucose, 290/zg/ml 
glutamine, 25mM KCI) or serum- (Eagle's 
minimal essential medium containing 30/zg/ml in- 
sulin, 30 nM sodium selenite, 33 mM glucose, 
290/~g/ml glutamine, 25 U/ml penicillin, 
25/zg/ml streptomycin, 25 mM KCI). In the case 
of drug additions the drugs were present hrough- 
out the period of culture. After 8 h the cells were 
fixed with 4070 formaldehyde in PBS, examined on 
an Olympu s inverted IMT microscope and the 
percentage of granule cells with processes cored. 
In each well 350 cells were counted. 
3. RESULTS 
Cultures of dissociated cells of the early post- 
natal rat cerebellum consist predominantly [19,20] 
of granule cells (92-95070 of the cell population) 
, which can easily be distinguished from the other 
i 
cell types by their small size (diameter 5-7.5 #m). 
Granule cells were grown in sparsely seeded 
cultures to minimise cellular interactions and to 
faolitate assessment of neurite outgrowth. When 
placed into culture, some granule cells begin to ex- 
tend neurites within minutes [21]. By 8 h after 
plating 23_  1°70 (n = 35) of cells had extended 
neurites (fig. 1) and were examined at this time in 
order to assess the rate of initiation of neurite out- 
growth rather than long term neurite growth and 
cell survival. By 1 day in culture most granule cells 
have extended neurites. The neurites are axonal in 
nature since after 1 or more days in culture they 
contain synaptic vesicles [22]. 
Addition of low concentrations (30/zM) of 
NMDA to the cultures had little effect on neurite 
outgrowth and higher concentrations were neuro- 
toxic (not shown). Since granule cells in culture 
release glutamate the possibility that endogenous 
glutamate was sufficient o stimulate neurite out- 
growth was tested. In serum containing cultures in 
which glutamate receptors were blocked by the 
broad-spectrum glutamate receptor antagonist 
kynurenate [23] neurite outgrowth was inhibited 
Fig. 1. Phase-contrast micrographs ofgranule cells fixed after 8 h in culture in a serum* medium. The three panels how 
the range of morphologies of granule cell neurites (arrows). The granule cells can easily be distinguished from non- 
neuronal cells (arrowheads). Bar, 10/~m. 
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by 43°70 (fig.2). Kynurenate also inhibited neurite 
outgrowth in serum- cultures by 54o7o (fig.2) show- 
ing that serum was not the sole source of glutamate 
in the cultures. These results suggest hat endo- 
genous glutamate released by granule cells in 
culture is sufficient o stimulate neurite outgrowth. 
In order to exclude the possibility that the in- 
hibitory effect of kynurenate was a non-specific ef- 
fect of the drug rather than an effect on glutamate 
receptors we examined the effect of addition of ex- 
ogenous glutamate on the kynurenate inhibition. 
As shown in fig.3 exogenous glutamate prevented 
the inhibition of neurite outgrowth by kynurenate 
consistent with a direct effect of the antagonist on 
glutamate receptors. 
The role of NMDA receptors in the stimulation 
of neurite outgrowth by endogenous glutamate 
was examined by growing the cells in the presence 
of the selective NMDA receptor antagonist [3,4] 
D-2-amino-5-phosphonovalerate (APV). APV in- 
hibited neurite outgrowth to the same extent as 
kynurenate (fig.3) and the inhibition by APV was 
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Fig.2. Effect of kynurenate on neurite outgrowth from 
granule cells in serum + and serum- cultures. Granule 
cells were grown in the indicated medium in the presence 
or absence of 3 mM kynurenate. Data shown are the 
percentage of cells with neurites from counts of 350 cells 
in 4 wells per treatment. * p<0.001 compared to the 
respective control. 
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Fig.3. Effect of kynurenate and APV on neurite out- 
growth from granule cells in serum + cultures. (a) 3 mM 
kynurenate; (b) 3 mM kynurenate + 10/~M glutamate; 
(c) 3 mM kynurenate + 100/~M glutamate; (d) 3 mM 
kynurenate + 250/zM glutamate; (e) 3 mM kynurenate 
+ 1 mM glutamate; (f) 30 mM DL-APV; (g) 300/zM 
DL-APV; (h) 1 mM DL-APV. The data shown are ex- 
pressed as percentage inhibition of neurite outgrowth 
and are taken from 4-10 wells per treatment. In control 
wells 25 + 2°7o (n = 16) of granule cells had neurites. 
* p<0.001; ** p<0.02 compared to control. 
virtually maximal at 30/~M DL-APV. The 
specificity of the inhibitory effect of APV was 
demonstrated in a separate series of experiments in
which 30/~M DL-APV inhibited neurite outgrowth 
by 43 +_ 1307o (n -- 4) but the inhibition was reduced 
to 0.2 + 0.2°70 (n = 4) when 30/~M NMDA was 
also present. 
The requirement for endogenous glutamate for 
normal neurite outgrowth in culture was also 
demonstrated by enzymatic removal of glutamate 
from the culture medium. Serum + cultures were 
maintained in the presence of 2 mM pyruvate and 
1 unit/ml glutamate pyruvate transaminase which 
should result in conversion of endogenous 
glutamate to c~-ketoglutarate. This treatment 
resulted in a 52.5 + 3.4°70 (n = 7) inhibition of 
neurite outgrowth. 
4. DISCUSSION 
The results presented here suggest that endo- 
genous glutamate released by granule cells in 
culture stimulates neurite outgrowth. This action 
of glutamate appears to be mediated by the 
NMDA class of glutamate receptors. Glutamate 
analogues have been shown to stimulate produc- 
tion of cGMP [24,25] and inositol phosphates [20] 
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in granule cell cultures. The production of both of 
these messengers was not restricted to NMDA but 
was seen after activation of all three glutamate 
receptor types. However, a major difference be- 
tween NMDA and non-NMDA receptor agonists is 
the specific ability of NMDA to open channels 
which allow Ca 2÷ influx [5] and a rise in cytosolic 
free Ca 2÷ [6,7]. We have found that NMDA 
elevates cytosolic free calcium in cerebellar granule 
cells in culture (our unpublished observations). 
Cytosolic free calcium has been suggested to be in- 
volved in the control of neurite outgrowth [8-10] 
and so it is likely that the mode of action of 
glutamate in stimulating neurite outgrowth in- 
volves the NMDA-receptor mediated rise in cyto- 
solic calcium. Consistent with this we found 
(unpublished) that addition of 3 mM EGTA to 
granule cell cultures inhibited neurite outgrowth by 
80o7o. This effect, however, could also involve in- 
hibition of cellular adhesion. 
The NMDA receptor is partially inhibited at 
physiological concentrations (1 mM) of Mg 2+ and 
this block is overcome by depolarisation. In our 
standard culture conditions with 0.8 mM Mg 2÷ in 
the medium the Mg2+-block would be at least par- 
tially overcome by depolarisation by the 25 mM 
K ÷ present. It is also possible that immature 
granule cells may respond to NMDA without addi- 
tional depolarisation since it has recently been 
shown that while the resting membrane potential 
of mature granule cells in culture is -60  mV that 
of immature granule ceils is - 30 to - 35 mV [27]. 
NMDA receptors are also regulated by glycine [28] 
which increases their sensitivity to agonist. The 
culture medium used in this study did not contain 
added glycine but the possibility does exist that the 
action of glutamate on NMDA receptors in the 
cultures could have been potentiated by glycine 
released from granule cells. 
The findings of this study suggest hat, at least 
for the cerebellar granule cell, glutamate could 
have a role in the stimulation of neurite outgrowth 
during development. The conditions under which 
glutamate stimulates neurite outgrowth in vivo re- 
main to be determined as does the sensitivity of 
other developing neurons to this widespread 
neurotransmitter. It is of interest hat higher levels 
of responsiveness to NMDA have been found for 
immature cerebellar granule cells, Purkinje cells 
[13] and visual cortex neurons [29] compared to 
these cell types in the adult brain. Whether these 
developmental changes are related to an important 
role of the NMDA receptor at critical stages of 
brain development is as yet unknown. 
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